The role of calcium in the central effects of biogenic amines.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000200:Action Potentials / Q000187:drug effects; D000613:Aminobutyrates / Q000037:antagonists & inhibitors; D000818:Animals; D001001:Anura; D001679:Biogenic Amines / Q000502:physiology*; D002118:Calcium / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology; D003035:Cobalt / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D006633:Histamine Antagonists; D007811:Lanthanum / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008322:Mammals; D008345:Manganese / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D008974:Mollusca; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D012702:Serotonin Antagonists; D009435:Synaptic Transmission / Q000187:drug effects; D014700:Verapamil / Q000494:pharmacology
D000613:Aminobutyrates; D001679:Biogenic Amines; D006633:Histamine Antagonists; D012702:Serotonin Antagonists; D003035:Cobalt; D000431:Ethanol; D008345:Manganese; D007811:Lanthanum; D014700:Verapamil; D008274:Magnesium; D000109:Acetylcholine; D002118:Calcium; D009638:Norepinephrine